136 related articles for article (PubMed ID: 36946608)
1. Significance of extraprostatic extension by Grade Groups 1-3 prostatic carcinoma on needle biopsy.
Zhao J; Epstein J
Prostate; 2023 Jun; 83(8):809-813. PubMed ID: 36946608
[TBL] [Abstract][Full Text] [Related]
2. Extraprostatic extension of prostatic adenocarcinoma on needle core biopsy: report of 72 cases with clinical follow-up.
Miller JS; Chen Y; Ye H; Robinson BD; Brimo F; Epstein JI
BJU Int; 2010 Aug; 106(3):330-3. PubMed ID: 20002671
[TBL] [Abstract][Full Text] [Related]
3. PIN-like (Ductal) Adenocarcinoma of the Prostate.
Paulk A; Giannico G; Epstein JI
Am J Surg Pathol; 2018 Dec; 42(12):1693-1700. PubMed ID: 30138215
[TBL] [Abstract][Full Text] [Related]
4. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis.
Egan AJ; Bostwick DG
Am J Surg Pathol; 1997 Dec; 21(12):1496-500. PubMed ID: 9414194
[TBL] [Abstract][Full Text] [Related]
5. Metastatic potential to regional lymph nodes with Gleason score ≤7, including tertiary pattern 5, at radical prostatectomy.
Diolombi ML; Epstein JI
BJU Int; 2017 Jun; 119(6):872-878. PubMed ID: 27496532
[TBL] [Abstract][Full Text] [Related]
6. Clinical, Pathological and Oncologic Findings of Radical Prostatectomy with Extraprostatic Extension Diagnosed on Preoperative Prostate Biopsy.
Faisal FA; Tosoian JJ; Han M; Macura KJ; Pavlovich CP; Lotan TL
J Urol; 2019 May; 201(5):937-942. PubMed ID: 30414957
[TBL] [Abstract][Full Text] [Related]
7. Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.
Tosoian JJ; Chappidi M; Feng Z; Humphreys EB; Han M; Pavlovich CP; Epstein JI; Partin AW; Trock BJ
BJU Int; 2017 May; 119(5):676-683. PubMed ID: 27367645
[TBL] [Abstract][Full Text] [Related]
8. Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate Cancer.
Goldberg H; Ramiz AH; Glicksman R; Salgado NS; Chandrasekar T; Klaassen Z; Wallis CJD; Hosni A; Moraes FY; Ghai S; Kulkarni GS; Hamilton RJ; Perlis N; Toi A; Chung P; Evans A; van der Kwast T; Finelli A; Fleshner N; Berlin A
Eur Urol Oncol; 2019 Feb; 2(1):88-96. PubMed ID: 30929849
[TBL] [Abstract][Full Text] [Related]
9. Prostatic Ductal Adenocarcinoma Controlled for Cancer Grade and Tumor Volume Does Not Have an Independent Effect on Adverse Radical Prostatectomy Outcomes Compared to Usual Acinar Prostatic Adenocarcinoma.
Iakymenko OA; Lugo I; Kwon D; Zhao W; Hayee A; Punnen S; Parekh DJ; Pollack A; Ritch CR; Gonzalgo ML; Stoyanova R; Jorda M; Kryvenko ON
Urology; 2020 Mar; 137():108-114. PubMed ID: 31711982
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy.
Yaxley W; Delahunt B; Yaxley J; Thunders MC; Kenwright DN; Egevad L; Samaratunga H
Pathology; 2022 Oct; 54(6):694-699. PubMed ID: 35613972
[TBL] [Abstract][Full Text] [Related]
11. High-grade prostatic adenocarcinoma present in a single biopsy core is associated with increased extraprostatic extension, seminal vesicle invasion, and positive surgical margins at prostatectomy.
Chaux A; Fajardo DA; Gonzalez-Roibon N; Partin AW; Eisenberger M; DeWeese TL; Netto GJ
Urology; 2012 Apr; 79(4):863-8. PubMed ID: 22173174
[TBL] [Abstract][Full Text] [Related]
12. Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.
Flood TA; Schieda N; Keefe DT; Breau RH; Morash C; Hogan K; Belanger EC; Mai KT; Robertson SJ
Virchows Arch; 2016 Sep; 469(3):313-9. PubMed ID: 27394432
[TBL] [Abstract][Full Text] [Related]
13. Intermediate Grade Prostate Cancer and Risk for Adverse Pathology Radical Prostatectomy: Implications for Partial Gland Ablation Case Selection.
Stangl-Kremser J; Patel N; Hu JC
Clin Genitourin Cancer; 2023 Aug; 21(4):491-496. PubMed ID: 37246010
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of morphological patterns of Gleason grade 5 prostatic adenocarcinoma diagnosed on needle biopsy.
Franklin A; Delahunt B; Egevad L; Yaxley J; Johannsen S; Gianduzzo T; Ganter J; Pecoraro C; Thunders M; Samaratunga H
Pathology; 2021 Feb; 53(2):199-204. PubMed ID: 33386122
[TBL] [Abstract][Full Text] [Related]
15. Percentage of Gleason pattern 4 and tumor volume predict adverse pathological stage and margin status at radical prostatectomy in grade Group 2 and grade Group 3 prostate cancers.
Iakymenko OA; Lugo I; Briski LM; Nemov I; Punnen S; Kwon D; Pollack A; Stoyanova R; Parekh DJ; Jorda M; Gonzalgo ML; Kryvenko ON
Prostate; 2021 Sep; 81(12):866-873. PubMed ID: 34184782
[TBL] [Abstract][Full Text] [Related]
16. The Gleason pattern 4 in radical prostatectomy specimens in current practice - Quantification, morphology and concordance with biopsy.
de Souza MF; de Azevedo Araujo ALC; da Silva MT; Athanazio DA
Ann Diagn Pathol; 2018 Jun; 34():13-17. PubMed ID: 29661718
[TBL] [Abstract][Full Text] [Related]
17. Limited Adenocarcinoma of the Prostate on Needle Core Biopsy.
Bell PD; Teramoto Y; Gurung PMS; Yang Z; Miyamoto H
Arch Pathol Lab Med; 2022 Apr; 146(4):469-477. PubMed ID: 35020802
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Significance of Perineural Invasion by Prostate Cancer on Needle Core Biopsy: Involvement of Single Versus Multiple Sextant Sites.
Bell PD; Teramoto Y; Gurung PMS; Numbere N; Yang Z; Miyamoto H
Arch Pathol Lab Med; 2022 Oct; 146(10):1252-1257. PubMed ID: 35020791
[TBL] [Abstract][Full Text] [Related]
19. Tertiary Gleason pattern 5 on needle biopsy predicts greater tumour volume on radical prostatectomy.
Ranaweera M; Samaratunga H; Duffy D; Klopfer K; Brunelli M; Martignoni G; Delahunt B
Pathology; 2011 Dec; 43(7):693-6. PubMed ID: 22002115
[TBL] [Abstract][Full Text] [Related]
20. Definitive pathology at radical prostatectomy is commonly favorable in men following initial active surveillance.
Hong SK; Sternberg IA; Keren Paz GE; Kim PH; Touijer KA; Scardino PT; Eastham JA
Eur Urol; 2014 Aug; 66(2):214-9. PubMed ID: 23954083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
